SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Electro Scientific Industries Inc – ‘10-Q’ for 12/30/17 – ‘EX-10.1’

On:  Tuesday, 2/6/18, at 5:12pm ET   ·   For:  12/30/17   ·   Accession #:  726514-18-8   ·   File #:  0-12853

Previous ‘10-Q’:  ‘10-Q’ on 11/7/17 for 9/30/17   ·   Next:  ‘10-Q’ on 8/7/18 for 6/30/18   ·   Latest:  ‘10-Q’ on 1/30/19 for 12/29/18

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size

 2/06/18  Electro Scientific Industries Inc 10-Q       12/30/17   80:6.4M

Quarterly Report   —   Form 10-Q   —   Sect. 13 / 15(d) – SEA’34
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-Q        Quarterly Report                                    HTML    547K 
 2: EX-10.1     Material Contract                                   HTML     33K 
 3: EX-10.2     Material Contract                                   HTML     68K 
 4: EX-31.1     Certification -- §302 - SOA'02                      HTML     29K 
 5: EX-31.2     Certification -- §302 - SOA'02                      HTML     29K 
 6: EX-32.1     Certification -- §906 - SOA'02                      HTML     24K 
 7: EX-32.2     Certification -- §906 - SOA'02                      HTML     24K 
14: R1          Document and Entity Information                     HTML     47K 
15: R2          Consolidated Balance Sheets                         HTML    108K 
16: R3          Consolidated Balance Sheets (Parenthetical)         HTML     45K 
17: R4          Consolidated Statements of Operations               HTML     80K 
18: R5          CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS       HTML     40K 
                Statement                                                        
19: R6          Consolidated Statements of Comprehensive Loss       HTML     29K 
                (Parenthetical)                                                  
20: R7          Condensed Consolidated Statements of Cash Flows     HTML    127K 
21: R8          The Company                                         HTML     40K 
22: R9          Recent Accounting Pronouncements                    HTML     42K 
23: R10         Fair Value Measurements                             HTML    200K 
24: R11         Inventories                                         HTML     31K 
25: R12         Other Assets                                        HTML     37K 
26: R13         Accrued Liabilities (Current) Other liabilities     HTML     38K 
                (Notes)                                                          
27: R14         Product Warranty                                    HTML     41K 
28: R15         Deferred Revenue                                    HTML     43K 
29: R16         Long-term Debt (Notes)                              HTML     42K 
30: R17         Revolving Credit Facility (Notes)                   HTML     25K 
31: R18         Commitments & Contingencies (Notes)                 HTML     25K 
32: R19         Shareholders' Equity                                HTML     25K 
33: R20         Accumulated Other Comprehensive Income (Loss)       HTML     45K 
                Accumulated Other Comprehensive Income (Loss)                    
                (Notes)                                                          
34: R21         Share-Based Compensation                            HTML     45K 
35: R22         Product and Geographic Information (Notes)          HTML     60K 
36: R23         Restructuring and Cost Management Plans             HTML     98K 
37: R24         (Loss) Earnings Per Share                           HTML     50K 
38: R25         Business Acquisitions                               HTML     38K 
39: R26         Income Taxes (Notes)                                HTML     29K 
40: R27         Fair Value Measurements (Tables)                    HTML    195K 
41: R28         Inventories (Tables)                                HTML     32K 
42: R29         Other Assets (Tables)                               HTML     33K 
43: R30         Accrued Liabilities (Current) Other Liabilities     HTML     39K 
                Disclosure (Tables)                                              
44: R31         Product Warranty (Tables)                           HTML     40K 
45: R32         Deferred Revenue (Tables)                           HTML     41K 
46: R33         Long-term Debt Debt Outstanding (Tables)            HTML     30K 
47: R34         Share-Based Compensation Expense (Tables)           HTML     40K 
48: R35         Product and Geographic Information (Tables)         HTML     61K 
49: R36         Restructuring and Cost Management Plans (Tables)    HTML     75K 
50: R37         Earnings (Loss) Per Share (Tables)                  HTML     49K 
51: R38         Basis of Presentation Cash and Cash Equivalents     HTML     33K 
                and Restricted Cash reconciliation (Details)                     
52: R39         Fair Value Measurements - Investments (Details)     HTML     60K 
53: R40         Fair Value Measurements Fair Value Hierarchy        HTML    135K 
                (Details)                                                        
54: R41         Trade Accounts Receivable (Details)                 HTML     31K 
55: R42         Inventories - Components of Inventories (Details)   HTML     32K 
56: R43         Other Assets (Details)                              HTML     42K 
57: R44         Other Assets - Additional Information (Details)     HTML     24K 
58: R45         Other Assets Other assets other details (Details)   HTML     24K 
59: R46         Accrued Liabilities (Details)                       HTML     45K 
60: R47         Product Warranty (Details)                          HTML     35K 
61: R48         Deferred Revenue (Details)                          HTML     35K 
62: R49         Long-term Debt (Details)                            HTML     24K 
63: R50         Long-term Debt Long-term debt table (Details)       HTML     30K 
64: R51         Long-term Debt Maturities of LT Debt (Details)      HTML     35K 
65: R52         Shareholders' Equity - Share repurchase (Details)   HTML     23K 
66: R53         Accumulated Other Comprehensive Income (Loss)       HTML     65K 
                (Details)                                                        
67: R54         Share-Based Compensation - Expense (Details)        HTML     47K 
68: R55         Product and Geographic Information Revenue from     HTML     36K 
                Product Market (Details)                                         
69: R56         Product and Geographic Information Revenue from     HTML     31K 
                Geographic Location table (Details)                              
70: R57         Restructuring and Cost Management Plans - Amounts   HTML     51K 
                Related to Restructuring Costs Payable (Details)                 
71: R58         Restructuring and Cost Management Plans Q4 FY17     HTML     52K 
                Restructuring Plan Expected Costs (Details)                      
72: R59         Restructuring and Cost Management Plans Q4 FY17     HTML     64K 
                Restructuring Plan Accrual Reconciliation                        
                (Details)                                                        
73: R60         Restructuring and Cost Management Plans Chelmsford  HTML     32K 
                Restructuring Plan Accrual (Details)                             
74: R61         Earnings (Loss) Per Share - Reconciliation of       HTML     39K 
                Weighted Average Shares Outstanding Used in                      
                Calculation of Basic and Diluted Earnings Per                    
                Share (Details)                                                  
75: R62         Earnings (Loss) Per Share - Additional Information  HTML     25K 
                (Details)                                                        
76: R63         Business Acquisitions - Allocation of Purchase      HTML     63K 
                Price of Assets Acquired and Liabilities Assumed                 
                Based on the Fair Value (Details)                                
77: R64         Business Acquisitions Business Acquisition details  HTML     34K 
                (Details)                                                        
79: XML         IDEA XML File -- Filing Summary                      XML    138K 
78: EXCEL       IDEA Workbook of Financial Reports                  XLSX     73K 
 8: EX-101.INS  XBRL Instance -- esio-20171230                       XML   1.97M 
10: EX-101.CAL  XBRL Calculations -- esio-20171230_cal               XML    201K 
11: EX-101.DEF  XBRL Definitions -- esio-20171230_def                XML    637K 
12: EX-101.LAB  XBRL Labels -- esio-20171230_lab                     XML   1.18M 
13: EX-101.PRE  XBRL Presentations -- esio-20171230_pre              XML    780K 
 9: EX-101.SCH  XBRL Schema -- esio-20171230                         XSD    145K 
80: ZIP         XBRL Zipped Folder -- 0000726514-18-000008-xbrl      Zip    174K 


‘EX-10.1’   —   Material Contract


This Exhibit is an HTML Document rendered as filed.  [ Alternative Formats ]



 <!   C:   C: 
  Exhibit  

SEPARATION AND RELEASE AGREEMENT
This Agreement is entered into by and between Electro Scientific Industries, Inc. (“ESI”), and Paul R. Oldham (“Employee”) with respect to the following facts:

A.    Employee's employment with ESI terminates on December 4, 2017.

B.ESI and Employee desire to enter into this Agreement regarding Employee's termination. Employee agrees to reaffirm this Agreement on the last day of employment.

The parties agree as follows:

1.
Wages. On Employee’s last day of employment, Employee received all earned wages and, a pro-rated portion of your special bonus in the amount of Seventy-Five Thousand dollars ($75,000) less applicable witholdings.

2.    Separation Pay. In consideration of Employee signing and abiding by the covenants and releases given herein, ESI will pay Employee total of Six Hundred and One-Thousand, Eight-Hundred and Twenty-Two dollars ($601,822), less applicable withholdings (“Separation Pay”). This sum includes an amount equal to six (6) months’ family Medical and Dental COBRA payments.

3.    Resignation. ESI agrees to allow Employee to resign from his employment with ESI. Employee acknowledges that his employment with Company has ended.

4.    Effective Date. The Effective Date of this Agreement shall be the 8th day after Employee properly signs it, as described in Paragraph 9 below.

6.    Confidential Information; Return of Property; Non-disparagement and Cooperation. Employee agrees not to use or disclose confidential, proprietary or trade secret information learned while an employee of ESI or its predecessors, including the terms of this Agreement, and covenants not to breach that duty. Confidential, proprietary, and trade secret information may include manufacturing processes, business plans, customer lists, drawings, documents, reports, facilities, formulas, computer data, computer programs (including algorithms, flowcharts, source code, object code, and firmware). This Agreement not to disclose confidential information is consistent with the ESI Employee Confidentiality and Assignment Agreement (“Confidentiality Agreement”), which, if signed by Employee, continues to apply after employment has ended. Employee agrees to return any and all ESI property and/or information in Employee’s possession. Both the Company and, the Employee agree not to disparage or make false, adverse or derogatory remarks about ESI or the Employee. Employee also agrees to fully cooperate and be reasonably available to ESI in any pending or future dispute or proceeding in which Employee may have knowledge of potentially relevant information.

7.    General Release. Employee acknowledges that Employee would not be entitled to receive the Separation Pay provided for herein absent Employee’s execution of and




compliance with this Agreement. In consideration of the Separation Pay and other benefits, Employee, individually and on behalf of Employee’s spouse, domestic partner, heirs and assigns (as applicable), to the fullest extent permitted under applicable law, unconditionally releases and discharges ESI, its subsidiaries, any related corporations and/or entities and each entity’s respective directors, officers, shareholders, employees, agents, successors and assigns, in their individual and representative capacities (collectively “Releasees”), from any and all known or unknown liability, damages claims, causes of action or suits of any type related directly or indirectly to Employee's employment with ESI, and the termination of Employee's employment with ESI, including claims under any common law theories, including but not limited to, breach of contract or tort or tort-like theories and under any local, state or federal, constitutional, civil rights, labor, and employment laws, including but not limited to, Employee Retirement Income Security Act (ERISA), Title VII of the Civil Rights Act of 1964, the Post Civil War Civil Rights Acts (42 USC §§ 1981‑1988), the Civil Rights Act of 1991, the Equal Pay Act, Older Workers’ Benefit Protection Act, the Age Discrimination in Employment Act, the Americans with Disabilities Act, the Worker Adjustment and Retraining Notification Act, the Rehabilitation Act of 1973, the Uniformed Services Employment and Reemployment Rights Act, the Fair Labor Standards Act, Executive Order 11246, the Sarbanes-Oxley Act, and the Family and Medical Leave Act, all as amended, including any regulations or guidelines thereunder.

This Release shall not affect any rights that Employee may have under health insurance plans, under the 401(k) plan or the non-qualified deferred compensation plan maintained by the Company, for unemployment or workers’ compensation benefits.

8.    Knowing and Voluntary Release of Rights Under the Older Workers’ Benefit Protection Act (the “Act”). Employee acknowledges that: (a) Employee has been encouraged in writing to consult with an attorney prior to executing this Agreement; (b) Employee has read the release and understands the effect of Employee’s release and that Employee is releasing legal rights; (c) Employee is aware of certain rights to which Employee may be entitled under certain statutes and laws identified in the release; (d) Employee has had adequate time to consider this Agreement; (e) Employee understands the Agreement and agrees to be bound by its terms; and (f) as consideration for executing this Agreement, Employee has received additional benefits and compensation of value to which Employee would not otherwise be entitled.

9.    Time for Consideration of Offer. Employee acknowledges that the Company provided Employee with this Agreement on or before December 4, 2017, and that the offer provided Employee with a period of twenty-one (21) days from the date of receipt to consider the offer and this Agreement (the "consideration period"). After Employee executes this Agreement, Employee has a period of seven (7) days in which Employee may revoke this Agreement in writing delivered to Tracey Jerijervi, Vice President of Human Resources or her designee and void Employee’s release of claims. In the event Employee has not signed and reaffirmed this Agreement by December 25, 2017, or if Employee timely revokes it, this offer will expire and Employee will not be entitled to the Separation Pay offered under this Agreement. If Employee reaffirms this Agreement on December 25, 2017, it will become effective and irrevocable on the day Employee reaffirms it (the “Effective Date”) and only then will Employee be entitled to the Separation Pay and severance benefits offered herein.

2




10.    General Provisions.

a.    Employee acknowledges that Employee has been given the opportunity to consult with legal counsel with respect to the matters referenced in this Agreement, and that Employee has obtained and considered the advice of legal counsel as Employee deems necessary or appropriate.

b.    This Agreement and the Confidentiality Agreement contain the entire agreement between Employee and ESI and there have been no promises, inducements or agreements not expressed in this Agreement.

c.    The provisions of this Agreement shall be considered severable, such that if any provision or part thereof shall at any time be held invalid under any law or ruling, any and all such other provision(s) or part(s) shall remain in full force and effect and continue to be enforceable.

d.    This Agreement shall be interpreted, construed, governed and enforced in accordance with the laws of the State of Oregon.

e.    This Agreement shall be binding upon and inure to the benefit of the parties hereto and their respective heirs, legal representatives, successors and assigns.

f.    Nothing in this Agreement shall be construed as an admission of any liability or any wrongdoing by either party to this Agreement.

The undersigned have executed this Agreement on the dates shown below.

Dated: ____________, 2017                                    
Paul R. Oldham


Dated: December 4, 2017        ELECTRO SCIENTIFIC INDUSTRIES, INC.
                
By:                            
Tracey Jerijervi
Vice President, Human Resources


3


Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘10-Q’ Filing    Date    Other Filings
Filed on:2/6/18
For Period end:12/30/17
12/25/17
12/4/174,  8-K
 List all Filings 
Top
Filing Submission 0000726514-18-000008   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Sun., Apr. 28, 4:57:14.1pm ET